Skip to Content

127 Results Found

  • Article
  • Open Access
2 Citations
4,827 Views
10 Pages

Recent studies have demonstrated that antidepressants could enhance functional recovery via neuroplasticity beyond solely treating depression. However, since Koreans typically show a greater aversion to seeking psychiatric care than citizens of Weste...

(This article belongs to the Special Issue Adult Psychiatry)
  • Article
  • Open Access
22 Citations
3,614 Views
16 Pages

Protective Effect of Escitalopram on Hepatocellular Carcinoma by Inducing Autophagy

  • Li-Jeng Chen,
  • Tsai-Ching Hsu,
  • Hsiang-Lin Chan,
  • Chiao-Fan Lin and ,
  • Jing-Yu Huang,
  • Robert Stewart,
  • Bor-Show Tzang and
  • Vincent Chin-Hung Chen
  • + 3 authors+ 0 author

17 August 2022

Background: Hepatocellular carcinoma (HCC) is an aggressive cancer with poor prognosis. Although recent research has indicated that selective serotonin reuptake inhibitors (SSRIs), including escitalopram, have anticancer effects, little is known abou...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
18 Citations
3,288 Views
12 Pages

Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram

  • Omar Gammoh,
  • Esam Y. Qnais,
  • Rabaa Y. Athamneh,
  • Bilal Al-Jaidi and ,
  • Deniz Al-Tawalbeh,
  • Sara Altaber,
  • Abdelrahim Alqudah,
  • Alaa A. A. Aljabali and
  • Murtaza M. Tambuwala
  • + 4 authors+ 0 author

21 September 2023

Oxidative stress and inflammation are implicated in depression. While selective serotonin reuptake inhibitors (SSRIs) like escitalopram are commonly prescribed as first-line treatments, their inconsistent efficacy and delayed onset of action necessit...

(This article belongs to the Topic Neuroprotection by Drugs, Nutraceuticals and Physical Activity, 2nd Volume)
  • Case Report
  • Open Access
3 Citations
5,924 Views
7 Pages

27 January 2024

We present the case of a 42-year-old female whose escitalopram use potentially contributed to a diagnosis of collagenous colitis. The patient presented with significant watery, nonbloody diarrhea, abdominal cramping and pain, and weight loss. Establi...

  • Article
  • Open Access
3 Citations
3,206 Views
16 Pages

Background/Objectives: Escitalopram, a first-line antidepressant, is primarily metabolized by CYP2C19. Its pharmacokinetics are altered during pregnancy. This study aims to predict maternal and fetal exposure to escitalopram during pregnancy and to p...

(This article belongs to the Special Issue Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling and Applications)
  • Article
  • Open Access
10 Citations
4,822 Views
13 Pages

Synergistic Effects of the Combinational Use of Escitalopram Oxalate and 5-Fluorouracil on the Inhibition of Gastric Cancer SNU-1 Cells

  • Vincent Chin-Hung Chen,
  • Jing-Yu Huang,
  • Bor-Show Tzang,
  • Tsai-Ching Hsu and
  • Roger S. McIntyre

19 December 2022

Owing to its high recurrence rate, gastric cancer (GC) is the leading cause of tumor-related deaths worldwide. Besides surgical treatment, chemotherapy is the most commonly used treatment against GC. However, the adverse events associated with chemot...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
347 Views
23 Pages

An Experimental and Computational Approach for the Utilization of Expired Escitalopram as a Corrosion Inhibitor for Carbon Steel

  • Abdur Rahman,
  • Salma Bilal,
  • Salma Gul,
  • Shamsa Munir and ,
  • Javaria Sadaf and
  • Bakhtiar Ali
  • + 1 author+ 0 author

Corrosion of carbon steel in acidic medium remains a major industrial concern, requiring efficient and economical corrosion inhibitors. In this work, expired Escitalopram was examined as a potential waste-derived corrosion inhibitor for carbon steel...

(This article belongs to the Special Issue Selected Papers from the 3rd International Online Conference on Corrosion and Materials Degradation (CMD 2026))
  • Article
  • Open Access
2,228 Views
11 Pages

Dietary Escitalopram Reduces Movement Variability and Enhances Behavioral Predictability in Drosophila melanogaster

  • Vadims Kolbjonoks,
  • Sergejs Popovs,
  • Ronalds Krams,
  • Giedrius Trakimas and ,
  • Māris Munkevics,
  • Tatjana Krama,
  • Markus J. Rantala,
  • Jorge Contreras-Garduño,
  • André Rodrigues de Souza and
  • Indrikis Krams
  • + 7 authors+ 2 authors

28 December 2025

Behavioral individuality, often termed animal personality, reflects consistent patterns of behavioral variability across individuals. In fruit flies (Drosophila melanogaster), pharmacological and dietary manipulations affecting neuromodulatory system...

  • Article
  • Open Access
8 Citations
3,875 Views
14 Pages

20 January 2023

The serotonin and kappa opioid receptor (KOR) systems are strongly implicated in disorders of negative affect, such as anxiety and depression. KORs expressed on axon terminals inhibit the release of neurotransmitters, including serotonin. The substan...

(This article belongs to the Section Molecular Biology)
  • Communication
  • Open Access
1 Citations
3,500 Views
14 Pages

Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade

  • Aneta Piwowarczyk-Nowak,
  • Artur Pałasz,
  • Aleksandra Suszka-Świtek,
  • Iwona Błaszczyk and ,
  • Katarzyna Bogus,
  • Barbara Łasut-Szyszka,
  • Marek Krzystanek and
  • John J. Worthington
  • + 3 authors+ 0 author

Background: Neuropeptide S (NPS) is a multifunctional regulatory factor that exhibits a potent anxiolytic activity in animal models. However, there are no reports dealing with the potential molecular interactions between the activity of selective ser...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
11 Citations
27,274 Views
10 Pages

How impactful is the use of Sertraline, Fluoxetine, and Escitalopram monotherapy on psychological distress among adults with depression in the real world? Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressant...

(This article belongs to the Special Issue Pharmacy Practice and Administration 2.0)
  • Article
  • Open Access
9 Citations
6,281 Views
9 Pages

Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial

  • James A. Blumenthal,
  • Patrick J. Smith,
  • Wei Jiang,
  • Alan Hinderliter and ,
  • Lana L. Watkins,
  • Benson M. Hoffman,
  • William E. Kraus,
  • Stephanie Mabe,
  • Lawrence Liao and
  • Andrew Sherwood
  • + 6 authors+ 1 author

Anxiety is common among patients with coronary heart disease (CHD) and is associated with a worse prognosis. UNWIND was a 12-week randomized clinical trial comparing exercise and escitalopram to placebo on measures of anxiety, depression, and CHD bio...

(This article belongs to the Special Issue Recent Advances in Sports Cardiology)
  • Article
  • Open Access
10 Citations
6,686 Views
10 Pages

Purpose: The pathophysiology of cervical dystonia (CD) is thought to be related to changes in dopamine and serotonin levels in the brain. We performed a double-blind trial with escitalopram (selective serotonin reuptake inhibitor; SSRI) in patients w...

(This article belongs to the Special Issue Dopamine Receptor in Health and Diseases)
  • Article
  • Open Access
12 Citations
4,559 Views
19 Pages

The Effect of Chronic Mild Stress and Escitalopram on the Expression and Methylation Levels of Genes Involved in the Oxidative and Nitrosative Stresses as Well as Tryptophan Catabolites Pathway in the Blood and Brain Structures

  • Paulina Wigner,
  • Ewelina Synowiec,
  • Paweł Jóźwiak,
  • Piotr Czarny and ,
  • Michał Bijak,
  • Katarzyna Białek,
  • Janusz Szemraj,
  • Piotr Gruca,
  • Mariusz Papp and
  • Tomasz Śliwiński
  • + 5 authors+ 0 author

Previous studies suggest that depression may be associated with reactive oxygen species overproduction and disorders of the tryptophan catabolites pathway. Moreover, one-third of patients do not respond to conventional pharmacotherapy. Therefore, the...

(This article belongs to the Special Issue Tryptophan in Nutrition and Health)
  • Article
  • Open Access
1,145 Views
22 Pages

30 June 2026

Objective: Disorders of gut–brain interaction (DGBIs) are characterized by functional impairments without identifiable organic causes, with their prevalence increasing with age. Emerging evidence suggests that selective serotonin reuptake inhib...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Article
  • Open Access
8 Citations
9,748 Views
15 Pages

Stress and escitalopram (an anti-stress medication) can affect brain functions and related gene expression. This study investigated the protective effects of long-term escitalopram administration on memory, as well as on hippocampal BDNF and BCL-2 ge...

(This article belongs to the Special Issue Animal Models of Neurological Disorders)
  • Article
  • Open Access
7 Citations
3,599 Views
17 Pages

The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression

  • Noelia Cantero-García,
  • Antonio Flores-Burgess,
  • David Ladrón de Guevara-Miranda,
  • Antonia Serrano and ,
  • Laura García-Durán,
  • Araceli Puigcerver,
  • Kjell Fuxe,
  • José Ángel Narváez,
  • Luis Javier Santín and
  • Carmelo Millón
  • + 6 authors+ 1 author

Alcohol use disorder (AUD) is highly prevalent, and over 50% of AUD patients also suffer major depressive disorders. Selective 5-HT reuptake inhibitors (SSRIs) can reduce rodent ethanol drinking but exert modest clinical efficacy in alcoholic individ...

(This article belongs to the Special Issue Biological Aspects of Drug Addiction)
  • Article
  • Open Access
69 Citations
9,592 Views
25 Pages

Escitalopram Targets Oxidative Stress, Caspase-3, BDNF and MeCP2 in the Hippocampus and Frontal Cortex of a Rat Model of Depression Induced by Chronic Unpredictable Mild Stress

  • Vlad Dionisie,
  • Adela Magdalena Ciobanu,
  • Vlad Alexandru Toma,
  • Mihnea Costin Manea and ,
  • Ioana Baldea,
  • Diana Olteanu,
  • Alexandra Sevastre-Berghian,
  • Simona Clichici,
  • Mirela Manea and
  • Gabriela Adriana Filip
  • + 6 authors+ 1 author

In recent years, escitalopram (ESC) has been suggested to have different mechanisms of action beyond its well known selective serotonin reuptake inhibition. The aim of this study is to investigate the effects of escitalopram on oxidative stress, apop...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
18 Citations
3,785 Views
15 Pages

Galanin(1-15) Potentiates the Antidepressant-like Effects Induced by Escitalopram in a Rat Model of Depression

  • Laura García-Durán,
  • Antonio Flores-Burgess,
  • Noelia Cantero-García,
  • Araceli Puigcerver and ,
  • José Ángel Narváez,
  • Kjell Fuxe,
  • Luis Santín,
  • Carmelo Millón and
  • Zaida Díaz-Cabiale
  • + 4 authors+ 0 author

7 October 2021

Selective 5-HT reuptake inhibitor antidepressants (SSRIs) are the first choice in major depressive disorder (MDD), but 50% of affected patients do not show improvement. Galanin(1-15) [GAL(1-15)] enhanced Fluoxetine antidepressant-like effects in an a...

(This article belongs to the Section Molecular Pharmacology)
  • Article
  • Open Access
3 Citations
4,092 Views
25 Pages

Cytotoxic Effect of Escitalopram/Etoposide Combination on Etoposide-Resistant Lung Cancer

  • Serap Özkaya Gül,
  • Beyzanur Şimşek,
  • Fidan Yıldız and
  • Esra Aydemir

Background: Antidepressants are a class of pharmaceuticals utilized for the management of many psychiatric disorders, including depression. A considerable number of antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), have b...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
44 Citations
7,873 Views
19 Pages

Fabrication and Characterization of Fast-Dissolving Films Containing Escitalopram/Quetiapine for the Treatment of Major Depressive Disorder

  • Manal E. Alkahtani,
  • Alhassan H. Aodah,
  • Omar A. Abu Asab,
  • Abdul W. Basit and ,
  • Mine Orlu and
  • Essam A. Tawfik
  • + 1 author+ 0 author

Major depressive disorder (MMD) is a leading cause of disability worldwide. Approximately one-third of patients with MDD fail to achieve response or remission leading to treatment-resistant depression (TRD). One of the psychopharmacological strategie...

(This article belongs to the Special Issue Electrospun Materials for Biomedical Applications)
  • Article
  • Open Access
6 Citations
4,637 Views
18 Pages

Identification of Photodegradation Products of Escitalopram in Surface Water by HPLC-MS/MS and Preliminary Characterization of Their Potential Impact on the Environment

  • Veronica Termopoli,
  • Viviana Consonni,
  • Davide Ballabio,
  • Roberto Todeschini and ,
  • Marco Orlandi and
  • Fabio Gosetti
  • + 1 author+ 0 author

The study concerns the photodegradation of the antidepressant escitalopram (ESC), the S-enantiomer of the citalopram raceme, both in ultrapure and surface water, considering the contribution of indirect photolysis through the presence of nitrate and...

(This article belongs to the Section Environmental Separations)
  • Article
  • Open Access
4 Citations
5,597 Views
17 Pages

Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis

  • Vincent Chin-Hung Chen,
  • Shao-Lan Huang,
  • Jing-Yu Huang,
  • Tsai-Ching Hsu and ,
  • Bor-Show Tzang and
  • Roger S. McIntyre
  • + 1 author+ 0 author

10 August 2023

Liver cancer is one of the most lethal malignant cancers worldwide. However, the therapeutic options for advanced liver cancers are limited and reveal scant efficacy. The current study investigated the effects of nivolumab (Niv) and escitalopram oxal...

(This article belongs to the Special Issue Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy)
  • Article
  • Open Access
16 Citations
4,978 Views
20 Pages

Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative

  • Muh. Akbar Bahar,
  • Pauline Lanting,
  • Jens H. J. Bos,
  • Rolf H. Sijmons and ,
  • Eelko Hak and
  • Bob Wilffert
  • + 1 author+ 0 author

28 November 2020

We explored the association between CYP2C19/3A4 mediated drug-gene-interaction (DGI), drug-drug-interaction (DDI) and drug-drug-gene-interaction (DDGI) and (es)citalopram dispensing course. A cohort study was conducted among adult Caucasians from the...

(This article belongs to the Special Issue Pharmacogenetics to Avoid Adverse Drug Reactions)
  • Article
  • Open Access
1,849 Views
11 Pages

Contrasting Effects of Larval Escitalopram and Serotonin-Synthesis Inhibitor on Adult Phototaxis in Drosophila w1118

  • Indrikis Krams,
  • Vadims Kolbjonoks,
  • Sergejs Popovs,
  • Māris Munkevics and ,
  • Ronalds Krams,
  • Giedrius Trakimas,
  • Markus J. Rantala,
  • Jorge Contreras-Garduño,
  • Priit Jõers and
  • Tatjana Krama
  • + 6 authors+ 1 author

20 November 2025

Phototaxis, the movement toward or away from light, is a fundamental behavior with ecological and evolutionary relevance. In Drosophila melanogaster, phototactic choice shows individual variability and has been linked to serotonergic signaling. Using...

(This article belongs to the Section Animal Science)
  • Article
  • Open Access
29 Citations
7,226 Views
19 Pages

29 January 2021

The functional suppression of serotonin (5-HT) type 7 receptor (5-HT7R) is forming a basis for scientific discussion in psychopharmacology due to its rapid-acting antidepressant-like action. A novel mood-stabilizing atypical antipsychotic agent, lura...

(This article belongs to the Special Issue Molecular Mechanisms of Mood Stabilizers)
  • Article
  • Open Access
11 Citations
11,471 Views
13 Pages

Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults

  • Philip E. Polychroniou,
  • Helen S. Mayberg,
  • W. Edward Craighead,
  • Jeffrey J. Rakofsky and ,
  • Vivianne Aponte Rivera,
  • Ebrahim Haroon and
  • Boadie W. Dunlop
  • + 2 authors+ 0 author

17 July 2018

Side effect profiles of antidepressants are relevant to treatment selection and adherence among patients with major depressive disorder (MDD), but several clinically-relevant characteristics of side effects are poorly understood. We aimed to compare...

  • Study Protocol
  • Open Access
13 Citations
7,024 Views
11 Pages

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial

  • Jeffrey R. Strawn,
  • Ethan A. Poweleit,
  • Jeffrey A. Mills,
  • Heidi K. Schroeder and ,
  • Zoe A. Neptune,
  • Ashley M. Specht,
  • Jenni E. Farrow,
  • Xue Zhang,
  • Lisa J. Martin and
  • Laura B. Ramsey
  • + 5 authors+ 0 author

12 November 2021

Current pharmacologic treatments for pediatric anxiety disorders (e.g., selective serotonin reuptake inhibitors (SSRIs)) frequently use “one size fits all” dosing strategies based on average responses in clinical trials. However, for some SSRIs, incl...

(This article belongs to the Special Issue Pharmacogenetics of Treating Anxiety & Depression)
  • Article
  • Open Access
9 Citations
5,860 Views
12 Pages

Effect of CYP2C19 Pharmacogenetic Testing on Predicting Citalopram and Escitalopram Tolerability and Efficacy: A Retrospective, Longitudinal Cohort Study

  • Mahmood Mahajna,
  • Rami Abu Fanne,
  • Matitiahu Berkovitch,
  • Elias Tannous and ,
  • Shlomo Vinker,
  • Ilan Green and
  • Ilan Matok
  • + 2 authors+ 0 author

Background—Various antidepressant agents are metabolized by the CYP2C19 enzyme, including Citalopram and Escitalopram. Variation in CYP2C19 expression might give rise to different plasma concentrations of the active metabolites, potentially aff...

(This article belongs to the Section Drug Discovery, Development and Delivery)
  • Article
  • Open Access
16 Citations
5,024 Views
21 Pages

16 September 2021

It has been established that enhancement of serotonergic transmission contributes to improvement of major depression; however, several post-mortem studies and experimental depression rodent models suggest that functional abnormalities of astrocytes p...

(This article belongs to the Special Issue Astrocytes: Emerging Roles in the Pathogenesis and Treatment of CNS Disorders 2.0)
  • Article
  • Open Access
12 Citations
6,953 Views
10 Pages

17 December 2019

Background: Elevated S100 calcium binding protein B (S100B) levels in systemic circulation may induce neuroinflammation and reflect greater blood–brain barrier (BBB) dysfunction. Neuroinflammation in patients with major depressive disorder (MDD), in...

(This article belongs to the Special Issue Antidepressants: Mechanistic Insights and Future Directions)
  • Article
  • Open Access
13 Citations
5,299 Views
13 Pages

Vitamins C and D Exhibit Similar Antidepressant Effects to Escitalopram Mediated by NOx and FKBPL in a Stress-Induced Mice Model

  • Omar Gammoh,
  • Aseel Ibrahim,
  • Esam Qnais,
  • Abdelrahim Alqudah and ,
  • Sara Altaber,
  • Alaa A. A. Aljabali and
  • Murtaza M. Tambuwala
  • + 2 authors+ 0 author

9 June 2023

The aim of this study was to investigate the potential antidepressant and anxiolytic effects of vitamin C and vitamin D in a stress-induced mouse model of depression, while also exploring the association between these effects and the levels of circul...

(This article belongs to the Special Issue Nutrition Interventions and Their Impact on Brain Health and Disease)
  • Article
  • Open Access
21 Citations
4,619 Views
17 Pages

6 February 2023

Evidence has shown the roles of taVNS and TECS in improving depression but few studies have explored their synergistic effects on MDD. Therefore, the treatment responsivity and neurological effects of TECAS were investigated and compared to escitalop...

(This article belongs to the Section Neuropsychiatry)
  • Article
  • Open Access
15 Citations
2,285 Views
16 Pages

3D-QSAR Design of New Escitalopram Derivatives for the Treatment of Major Depressive Disorders

  • Speranta AVRAM,
  • Catalin BUIU,
  • Daniel M. DUDA-SEIMAN,
  • Corina DUDA-SEIMAN and
  • Dan MIHAILESCU

5 May 2010

Antidepressants are psychiatric agents used for the treatment of different types of depression being at present amongst the most commonly prescribed drug, while their effectiveness and adverse effects are the subject of many studies and competing cla...

  • Article
  • Open Access
2 Citations
581 Views
18 Pages

Can We Well Assess the Relative Efficacy and Tolerability of a New Drug Versus Others at the Time of Marketing Authorization Using Mixed Treatment Comparisons? A Detailed Illustration with Escitalopram

  • Pierre-Michel Llorca,
  • Christophe Lançon,
  • Mélanie Brignone,
  • Caroline Painchault and ,
  • Benoit Rive,
  • Mondher Toumi and
  • Clément François
  • + 2 authors+ 0 author

Objective: To assess the variation of relative efficacy and tolerability of an antidepressant versus others based on both pre-marketing (registration studies) and post-marketing studies versus pre-marketing studies only in patients with major depress...

  • Article
  • Open Access
5 Citations
3,265 Views
21 Pages

St. John’s Wort Extract Ze 117 and Escitalopram Alter Plasma and Hippocampal Lipidome in a Rat Model of Chronic-Stress-Induced Depression

  • Hendrik Bussmann,
  • Swen Bremer,
  • Anne Marie Hernier,
  • Jürgen Drewe and ,
  • Hanns Häberlein,
  • Sebastian Franken,
  • Virginie Freytag,
  • Georg Boonen and
  • Veronika Butterweck
  • + 4 authors+ 0 author

26 November 2024

Chronic stress is a key factor in the development of depression. It leads to hyperactivation of the hypothalamic–pituitary–adrenal (HPA) axis, which in turn increases the formation of glucocorticoids (GCs). Chronically elevated GC levels...

(This article belongs to the Special Issue Lipid Metabolism and Biomarkers in Neural and Cardiometabolic Health)
  • Article
  • Open Access
2 Citations
4,284 Views
16 Pages

7 February 2025

Background: Bipolar disorder (BD) is a chronic condition associated with treatment resistance, cognitive decline, structural brain changes, and an approximately 13-year reduction in life expectancy compared to the general population. Depression in BD...

(This article belongs to the Section Omics/Informatics)
  • Brief Report
  • Open Access
2 Citations
3,032 Views
8 Pages

Melatonin Reduces Alcohol Drinking in Rats with Disrupted Function of the Serotonergic System

  • Ieva Poceviciute,
  • Rokas Buisas,
  • Osvaldas Ruksenas and
  • Valentina Vengeliene

26 February 2022

The reason for the limited treatment success of substance-use-related problems may be a causal heterogeneity of this disorder that, at least partly, is manifested as differences in substance-use motives between individuals. The aim of the present stu...

(This article belongs to the Section Mechanisms of Diseases)
  • Article
  • Open Access
106 Citations
12,099 Views
14 Pages

Impact of Antidepressants on Cytokine Production of Depressed Patients in Vitro

  • Alexander Munzer,
  • Ulrich Sack,
  • Roland Mergl,
  • Jeremias Schönherr and ,
  • Charlotte Petersein,
  • Stefanie Bartsch,
  • Kenneth C. Kirkby,
  • Katrin Bauer and
  • Hubertus Himmerich
  • + 4 authors+ 0 author

19 November 2013

The interplay between immune and nervous systems plays a pivotal role in the pathophysiology of depression. In depressive episodes, patients show increased production of pro-inflammatory cytokines such as interleukin (IL)-1β and tumor necrosis factor...

(This article belongs to the Collection Toxicity and Therapeutic Interventions in the Immune System)
  • Article
  • Open Access
39 Citations
5,913 Views
16 Pages

Fecal Microbiota Analysis in Patients Going through a Depressive Episode during Treatment in a Psychiatric Hospital Setting

  • Paweł Liśkiewicz,
  • Justyna Pełka-Wysiecka,
  • Mariusz Kaczmarczyk,
  • Igor Łoniewski and ,
  • Michał Wroński,
  • Agata Bąba-Kubiś,
  • Karolina Skonieczna-Żydecka,
  • Wojciech Marlicz,
  • Błażej Misiak and
  • Jerzy Samochowiec
  • + 5 authors+ 0 author

1 February 2019

Rationale: There is a worldwide prevalence of generalized anxiety and major depressive disorders (MDD). Gut–brain axis dysfunction, antibacterial activity, and modulatory effects of antidepressants toward intestinal bacteria have been shown bot...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Article
  • Open Access
7 Citations
3,983 Views
11 Pages

17 December 2022

A high-performance liquid chromatographic method was developed for the simultaneous determination of the related substances—three potential synthesis-related chemical impurities and the distomer—of escitalopram. The separation capacity of...

(This article belongs to the Section Analytical Chemistry)
  • Article
  • Open Access
2 Citations
2,393 Views
16 Pages

6 October 2025

This research prepared and characterised novel mixed coordination complexes derived from escitalopram with eugenol and curcumin to form (L1) and (L2), respectively. The complexes were prepared via Williamson ether synthesis and analysed by FTIR, UV&n...

(This article belongs to the Special Issue Metal Complexes Containing Bioactive Ligands: Structure and Biological Evaluation)
  • Protocol
  • Open Access
7 Citations
5,877 Views
15 Pages

A Double-Blind Randomized Trial to Investigate Mechanisms of Antidepressant-Related Dysfunctional Arousal in Depressed or Anxious Youth at Familial Risk for Bipolar Disorder

  • Duncan C. Honeycutt,
  • Melissa P. DelBello,
  • Jeffrey R. Strawn,
  • Laura B. Ramsey and ,
  • Luis R. Patino,
  • Kyle Hinman,
  • Jeffrey Welge,
  • David J. Miklowitz,
  • Booil Jo and
  • Manpreet K. Singh
  • + 10 authors+ 5 authors

20 June 2022

Antidepressants are standardly used to treat moderate to severe symptoms of depression and/or anxiety in youth but may also be associated with rare but serious psychiatric adverse events such as irritability, agitation, aggression, or suicidal ideati...

(This article belongs to the Section Pharmacogenetics)
  • Article
  • Open Access
30 Citations
8,279 Views
18 Pages

10 December 2019

Vortioxetine is a novel, multimodal antidepressant with unique targets, including the inhibition of the serotonin transporter (SET), of serotonin 5-HT3 (5-HT3R), and of 5-HT7 (5-HT7R) receptors and partial agonism to serotonin 5-HT1A (5-HT1AR) recept...

(This article belongs to the Special Issue Serotonin in Health and Disease)
  • Case Report
  • Open Access
1 Citations
8,098 Views
7 Pages

Successful Pharmacologic Treatment of Self-Bloodletting with Factitious Chronic Anemia (Lasthénie de Ferjol Syndrome) with High-Dose Serotonergic Medication: A Case Report

  • Stefan Mestermann,
  • Laura Rudtke,
  • Razvan-Marius Brazdis,
  • Thanos Tsaktanis and ,
  • Johannes Kornhuber and
  • Norbert Thürauf
  • + 1 author+ 0 author

14 March 2024

Self-induced bloodletting (SBL) is a very rare form of self-injury (SI) seen primarily in adolescents and young adults with personality and eating disorders. It can result in complications like malaise, fatigue, or iron-deficiency anemia (Lasth&eacut...

(This article belongs to the Section Psychiatric, Emotional and Behavioral Disorders)
  • Article
  • Open Access
2 Citations
2,468 Views
26 Pages

Cannabidiol Lipid Nanoparticles Stabilize Gut–Brain–Bone Axis Integrity and Enhance Neuroplasticity in Stressed Rats: A Comparison with Atomoxetine and Escitalopram

  • Sarawut Lapmanee,
  • Jitpatima Lumsutti,
  • Natthawut Charoenphon,
  • Anjaree Inchan and ,
  • Nittaya Boonmuen,
  • Prapimpun Wongchitrat,
  • Natchayaporn Thonapan,
  • Chaowalit Yuajit,
  • Piyaporn Surinlert and
  • Chaiyos Sirithanakorn
  • + 8 authors+ 3 authors

24 September 2025

Chronic stress induces mood disturbances, disrupts gut barrier function, and promotes low-grade systemic inflammation. This study assessed the therapeutic effects of atomoxetine (ATX), escitalopram (ESC), cannabidiol (CBD), and CBD-loaded lipid nanop...

(This article belongs to the Special Issue Nanoparticles in Molecular Pharmaceutics)
  • Article
  • Open Access
11 Citations
3,728 Views
16 Pages

Simultaneous Estimation of Escitalopram and Clonazepam in Tablet Dosage Forms Using HPLC-DAD Method and Optimization of Chromatographic Conditions by Box-Behnken Design

  • Ahmed I. Foudah,
  • Sultan Alshehri,
  • Faiyaz Shakeel,
  • Mohammed H. Alqarni and ,
  • Tariq M. Aljarba and
  • Prawez Alam
  • + 1 author+ 0 author

30 June 2022

The study aimed to develop a new reverse-phase high-performance liquid chromatography (RP-HPLC) method with diode array detection (DAD) detection for simultaneous estimation of escitalopram (EST) and clonazepam (CZP) in tablet dosage forms with a qua...

(This article belongs to the Special Issue Development of Chromatographic and Other Analytical Technologies for Pharmaceutical Drugs)
  • Article
  • Open Access
3 Citations
2,245 Views
14 Pages

Coffee Biomass-Based Carbon Material for the Electrochemical Determination of Antidepressant in Synthetic Urine

  • Francisco Contini Barreto,
  • Naelle Kita Mounienguet,
  • Erika Yukie Ito,
  • Quan He and
  • Ivana Cesarino

Escitalopram (ESC) is commonly prescribed as an antidepressant to enhance serotonin levels in the brain, effectively addressing conditions such as depression and anxiety. The COVID-19 pandemic, along with ongoing mental health crises, has exacerbated...

(This article belongs to the Special Issue Electrochemical Sensors and Biosensors for Food, Environmental and Biomedical Analysis)
  • Article
  • Open Access
15 Citations
3,521 Views
15 Pages

20 September 2023

Background: in a recent double-blind, placebo controlled RCT we demonstrated that selective inhibition of cyclo-oxygenase 2 (COX2) is an effective adjunctive strategy in treatment-resistant bipolar depression (TRBDD). To better clarify the mechanisms...

(This article belongs to the Special Issue Pharmacogenomics and Precision Medicine in Psychiatry: From Basic Research to Clinical Practice)
  • Article
  • Open Access
4 Citations
7,586 Views
18 Pages

Despite the recent promising results of MDMA (3,4-methylenedioxy-methamphetamine) as a psychotherapeutic agent and its history of misuse, little is known about its molecular mode of action. MDMA enhances monoaminergic neurotransmission in the brain a...

(This article belongs to the Section Computational and Theoretical Chemistry)

of 3